Skip to main content
. Author manuscript; available in PMC: 2021 Aug 9.
Published in final edited form as: J Card Fail. 2020 Sep 2;27(1):83–91. doi: 10.1016/j.cardfail.2020.08.013

Fig. 1.

Fig. 1.

Change in prednisone dose before and after treatment of cardiac sarcoidosis with tumor necrosis factor (TNF) alpha inhibitor. Boxplot of prednisone dose with median and interquartile range (black line and rectangles) and mean (red dots) dose. Prednisone dose at time of TNF alpha inhibitor initiation (n = 33) decreased significantly at both 6 months (n = 31, P = .001) and 12 months (n = 17, P = .002) when compared with the baseline dose.